Company news

vTv Therapeutics Inc. news in 2026

vTv Therapeutics Inc.'s news releases, calls and decks from 2026, newest first.

View company

vTv Therapeutics Reports Third Quarter 2026 Financial Results and Provides Corporate Update

November 5, 2026

vTv Therapeutics Announces First Participant Randomized in Phase 2a Pilot Study Evaluating Cadisegliatin in Individuals with Type 1 Diabetes (T1D) Using Hybrid Closed-Loop (HCL) Insulin Delivery Systems

October 27, 2026

vTv Therapeutics Announces Oral Presentation at Breakthrough T1D Clinical and Research Congress 2026

October 10, 2026

vTv Therapeutics Announces FDA Orphan Drug Designation for HPPD in Sickle Cell Disease

October 7, 2026

vTv Therapeutics to Host Virtual KOL Event on Hypoglycemia in Type 1 Diabetes and the Cadisegliatin Phase 3 Program on October 20, 2026

October 6, 2026

vTv Therapeutics Announces Completion of Enrollment in Phase 3 CATT1 Study of Cadisegliatin in Type 1 Diabetes (T1D)

October 5, 2026

vTv Therapeutics to Participate in September Investor Conferences

September 2, 2026

VTv Therapeutics Reports Second Quarter 2026 Financial Results and Provides Corporate Update

August 6, 2026

VTv Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(4)

June 3, 2026

VTv Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

June 2, 2026

vTv Therapeutics Reports First Quarter 2026 Financial Results and Provides Corporate Update

May 13, 2026

vTv Therapeutics to Participate in Upcoming May Investor Conferences

May 7, 2026

vTv Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

April 6, 2026

vTv Therapeutics to Participate in the 38th Annual ROTH Conference

March 15, 2026

vTv Therapeutics Announces Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Update

March 9, 2026

vTv Therapeutics to Participate in Upcoming Investor Conferences

February 13, 2026

vTv Therapeutics Amends License Agreement with Newsoara Biopharma Co. Ltd. for PDE4 inhibitor, HPP737

February 2, 2026

Decks in 2026